Top 23 Aprecia Pharmaceuticals investors
The most complete profiles first. Showing 23 of 23.
Adam GreeneVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Narendra NayakVerified
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Nicholas BishopVerified
Hedge Fund, Venture Capital, Investment Partner · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
April YoungVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
Greg PetersonVerified
Venture Capital, Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Howie FurstVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
Janice BourqueVerified
Venture Capital, Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Kevin BergVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Melanie GraceVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Michael DutraVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Nimesh ShahVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Raj SethVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Steve KuoVerified
Venture Capital, Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Thomas HarrisVerified
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Verified email available
Vincent MelletVerified
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Verified email available
James Flynn
Hedge Fund, Venture Capital, Investor · United States
Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information ServicesPortfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more
Contact details available
Avi Kometz
Hedge Fund, Investment Partner · United States
Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more
Contact details available
Cristy Barnes
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
John Eggbeer
Venture Capital, Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
Kevin Zeidan
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
Kristen Kosofsky
Venture Capital, Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
Seth Meyer
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
Wade Lin
Venture Debt · United States
Health CareDatabasesWomen FoundedEnterprise SoftwarePortfolio: CapLinked, Melinta, ChromaDex, AMSC and 87 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Aprecia Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 23 Aprecia Pharmaceuticals investors. 13 of them (57%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Debt Lenders (15), Venture Capital Firms (9) and Hedge Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Aprecia Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Series B (4).
Where are Aprecia Pharmaceuticals investors based?
Most are based in the United States (23).
Which companies have Aprecia Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Constellation Pharmaceuticals (23), Neos Therapeutics (23), Zosano Pharma (15), Contentful (15) and Metalysis (15).
How do I contact Aprecia Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.